Overview: Python and SQL form the core data science foundation, enabling fast analysis, smooth cloud integration, and ...

The Python Software Foundation (PSF) has an extra $1.5 million heading its way, after AI upstart Anthropic entered into a ...

Python IDEs now assist with writing, debugging, and managing code using built in AI supportDifferent IDEs serve different ...

Python''s popularity is surging. In 2025, it achieved a record 26.14% TIOBE index rating, the highest any language has ever reached, largely driven by AI and data trends. 58% of developers now use ...

Alphabet announced an plan to buy Intersect for $4.75 billion to secure power for US data centers. The move comes as tech firms face rising grid constraints and AI infrastructure project delays.

PALM BEACH COUNTY, Fla. — The proposed Project Tango data center in the Arden area is facing new opposition, as residents prepare to file a formal appeal that could temporarily halt the project’s ...

Local fights against new data centers are gaining bipartisan support across the US. Local fights against new data centers are gaining bipartisan support across the US. is a senior science reporter ...

Dec 17 (Reuters) - Oracle said ‌talks for an equity deal to ‌support its Michigan data center project remain on schedule and do not include Blue Owl Capital, after a report of stalled negotiations ...

LONDON, Dec 15 (Reuters) - Oaktree Capital‑backed Pure Data Centres said on Monday it plans to invest up to 1 billion euros ($1.17 billion) in a new Amsterdam campus, one of Europe's largest ...

A developer tied to data center projects in Archbald and Blakely now proposes to build four data centers in Dickson City across hundreds of mountainside acres above Business Route 6. Dickson City ...

For two weeks, a fight has been brewing over a massive data center project proposed in the Imperial Valley that is designed to power artificial intelligence technology. Now, the small city of Imperial ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...